Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China
· Delayed Price · Currency is CNY 14.45
+0.09 (0.63%)
Apr 29, 2026, 3:00 PM CST
SHA:600161 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,091 | 1,549 | 1,110 | 880.92 | 760.01 | Upgrade
|
| Depreciation & Amortization | 416.91 | 331.52 | 268.02 | 179.75 | 157.15 | Upgrade
|
| Other Amortization | 40.82 | 31.3 | 20.81 | 12.39 | 8.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.1 | -0.04 | 0.05 | -15.63 | -0.51 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.88 | 53.59 | 1.21 | 2.1 | 15.09 | Upgrade
|
| Loss (Gain) From Sale of Investments | -29.4 | -63.93 | -37.21 | -28.13 | -12 | Upgrade
|
| Provision & Write-off of Bad Debts | 62.15 | 9.74 | -0.65 | 1.26 | -0.14 | Upgrade
|
| Other Operating Activities | 428.57 | 572.18 | 405.98 | 327.41 | 314.14 | Upgrade
|
| Change in Accounts Receivable | -1,376 | -473.12 | 1,029 | -221.05 | -351.21 | Upgrade
|
| Change in Inventory | -172.04 | -579.84 | -514.44 | -181.5 | 30.96 | Upgrade
|
| Change in Accounts Payable | -113.34 | -613.1 | 98.57 | 167.42 | 66.15 | Upgrade
|
| Operating Cash Flow | 338.75 | 819.78 | 2,394 | 1,126 | 980.35 | Upgrade
|
| Operating Cash Flow Growth | -58.68% | -65.75% | 112.57% | 14.86% | 39.63% | Upgrade
|
| Capital Expenditures | -605.53 | -1,067 | -1,078 | -1,354 | -1,132 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.34 | 0.16 | 0.31 | 0.71 | 8.51 | Upgrade
|
| Cash Acquisitions | - | -963.78 | -1.58 | -36.36 | -29.33 | Upgrade
|
| Investment in Securities | 694 | 508.33 | -200 | - | -1,030 | Upgrade
|
| Other Investing Activities | 35.55 | -336.41 | 31.9 | -481.24 | -2.44 | Upgrade
|
| Investing Cash Flow | 124.35 | -1,859 | -1,247 | -1,871 | -2,185 | Upgrade
|
| Short-Term Debt Issued | 286.93 | - | - | - | - | Upgrade
|
| Total Debt Issued | 286.93 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -22.49 | -17.76 | -385.85 | -132.8 | -366.17 | Upgrade
|
| Net Debt Issued (Repaid) | 264.44 | -17.76 | -385.85 | -132.8 | -366.17 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 3,332 | Upgrade
|
| Common Dividends Paid | -494.34 | -247.17 | -94.02 | -157.21 | -163.84 | Upgrade
|
| Other Financing Activities | -212.49 | -105.36 | -28.21 | -88.19 | -27.6 | Upgrade
|
| Financing Cash Flow | -442.4 | -370.29 | -508.08 | -378.2 | 2,774 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | -0.04 | -0 | -0.05 | -0.01 | Upgrade
|
| Net Cash Flow | 20.68 | -1,410 | 638.58 | -1,123 | 1,570 | Upgrade
|
| Free Cash Flow | -266.78 | -247.63 | 1,316 | -228.02 | -151.35 | Upgrade
|
| Free Cash Flow Margin | -4.32% | -4.11% | 25.40% | -5.35% | -3.68% | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -0.13 | 0.66 | -0.11 | -0.08 | Upgrade
|
| Cash Income Tax Paid | 767.13 | 636.71 | 582.34 | 412.48 | 386.75 | Upgrade
|
| Levered Free Cash Flow | -453.35 | -1,336 | 1,047 | -348.46 | -470.29 | Upgrade
|
| Unlevered Free Cash Flow | -448.76 | -1,332 | 1,049 | -346.96 | -468.36 | Upgrade
|
| Change in Working Capital | -1,674 | -1,664 | 625.47 | -234.08 | -261.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.